TABLE 4.
Characteristic | No hematoma | Hematoma | p |
---|---|---|---|
No. of patients | 2375 | 20 | |
Age (years) | 48.8 ± 0.3 | 54.6 ± 4.6 | 0.11 |
Patient gender | |||
Female | 99.2 % | 0.8 % | 0.79 |
Male | 99.1 % | 0.9 % | |
Extent of operation | |||
Unilateral | 1044 (99.8 %) | 2 (0.2 %) | <0.01 |
Bilateral | 1226 (98.6 %) | 17 (1.4 %) | |
Extensive | 105 (99.1 %) | 1 (0.9 %) | |
Reoperative neck | 203 (98.5 %) | 3 (1.5 %) | 0.41 |
Antiplatelet use | |||
None | 1943 (99.3 %) | 14 (0.7 %) | 0.01 |
<325 mg aspirin | 209 (99.5 %) | 1 (0.5 %) | |
≥325 mg aspirin | 188 (98.4 %) | 3 (1.6 %) | |
Clopidogrel | 35 (94.6 %) | 2 (5.4 %) | |
Anticoagulant use | |||
None | 2311 (99.4 %) | 15 (0.6 %) | <0.001 |
Oral | 50 (96.2 %) | 2 (3.8 %) | |
Injectable | 14 (82.4 %) | 3 (17.6 %) | |
Use of either medication type | |||
None | 1893 (99.8 %) | 10 (0.5 %) | <0.001 |
One | 471 (98.1 %) | 9 (1.9 %) | |
Both | 11 (91.7 %) | 1 (8.3 %) |
Data are expressed as mean ± SEM or as n (%)